Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.
Ga Yeong YiMin Ju KimHyo In KimJinbong ParkSeung-Ho BaekPublished in: Antioxidants (Basel, Switzerland) (2022)
Despite recent developments in diagnosis and treatment options, cancer remains one of the most critical threats to health. Several anti-cancer therapies have been identified, but further research is needed to provide more treatment options that are safe and effective for cancer. Hyperthermia (HT) is a promising treatment strategy for cancer because of its safety and cost-effectiveness. This review summarizes studies on the anti-cancer effects of HT and the detailed mechanisms. In addition, combination therapies with anti-cancer drugs or natural products that can effectively overcome the limitations of HT are reviewed because HT may trigger protective events, such as an increase of heat shock proteins (HSPs). In the 115 reports included, the mechanisms related to apoptosis, cell cycle, reactive oxygen species, mitochondrial membrane potential, DNA damage, transcription factors and HSPs were considered important. This review shows that HT is an effective inducer of apoptosis. Moreover, the limitations of HT may be overcome using combined therapy with anti-cancer drugs or natural products. Therefore, appropriate combinations of such agents with HT will exert maximal effects to treat cancer.
Keyphrases
- papillary thyroid
- heat shock
- oxidative stress
- cell cycle
- dna damage
- squamous cell
- healthcare
- public health
- cell death
- lymph node metastasis
- stem cells
- transcription factor
- cell proliferation
- emergency department
- cell cycle arrest
- childhood cancer
- dna repair
- bone marrow
- mesenchymal stem cells
- heart rate
- health information
- drug delivery
- signaling pathway
- dna binding
- heat shock protein
- climate change
- combination therapy
- health promotion